• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050.法国和欧洲有多少痴呆症病例?2010-2050 年的替代预测和情景。
Eur J Neurol. 2010 Feb;17(2):252-9. doi: 10.1111/j.1468-1331.2009.02783.x. Epub 2009 Oct 1.
2
20-Year prevalence projections for dementia and impact of preventive policy about risk factors.20 年痴呆患病率预测及危险因素预防政策的影响。
Eur J Epidemiol. 2013 Jun;28(6):493-502. doi: 10.1007/s10654-013-9818-7. Epub 2013 Jun 12.
3
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.1990 - 2020年按病因划分的死亡率和残疾率的替代预测:全球疾病负担研究
Lancet. 1997 May 24;349(9064):1498-504. doi: 10.1016/S0140-6736(96)07492-2.
4
Total shoulder arthroplasty in France: An analysis of trends between 2009 and 2019 and projections to the year 2070.法国全肩关节置换术:2009 年至 2019 年趋势分析及 2070 年预测。
Orthop Traumatol Surg Res. 2024 Sep;110(5):103788. doi: 10.1016/j.otsr.2023.103788. Epub 2023 Dec 7.
5
Number of dementia sufferers in Europe between the years 2000 and 2050.2000年至2050年间欧洲痴呆症患者的数量。
Eur Psychiatry. 2003 Oct;18(6):306-13. doi: 10.1016/j.eurpsy.2003.03.003.
6
Impact of interventions scenarios targeting three main vascular risk factors on the future burden of dementia in France.针对法国三种主要血管危险因素的干预方案对未来痴呆症负担的影响。
Eur J Epidemiol. 2023 Apr;38(4):435-443. doi: 10.1007/s10654-023-00974-w. Epub 2023 Feb 28.
7
Impact of benzodiazepine consumption reduction on future burden of dementia.减少苯二氮䓬类药物使用对未来痴呆负担的影响。
Sci Rep. 2020 Sep 4;10(1):14666. doi: 10.1038/s41598-020-71482-0.
8
Projecting the impact of AIDS on mortality.预测艾滋病对死亡率的影响。
AIDS. 1998;12 Suppl 1:S29-39.
9
Projections of prevalence, lifetime risk, and life expectancy of Parkinson's disease (2010-2030) in France.法国帕金森病的患病率、终身风险和预期寿命预测(2010-2030 年)。
Mov Disord. 2018 Sep;33(9):1449-1455. doi: 10.1002/mds.27447. Epub 2018 Aug 25.
10
Dementia-free life expectancy in France.法国无痴呆症预期寿命。
Am J Public Health. 1994 Feb;84(2):232-6. doi: 10.2105/ajph.84.2.232.

引用本文的文献

1
A systematic study of molecular targets of cannabidiol in Alzheimer's disease.大麻二酚在阿尔茨海默病中分子靶点的系统研究。
J Alzheimers Dis Rep. 2024 Oct 11;8(1):1339-1360. doi: 10.1177/25424823241284464. eCollection 2024.
2
Determinants of Medical Direct Costs of Care among Patients of a Memory Center.记忆中心患者医疗直接成本的决定因素。
J Prev Alzheimers Dis. 2021;8(3):351-361. doi: 10.14283/jpad.2021.16.
3
Modeling Large Sparse Data for Feature Selection: Hospital Admission Predictions of the Dementia Patients Using Primary Care Electronic Health Records.基于大规模稀疏数据的特征选择模型:利用初级保健电子健康记录预测痴呆症患者的住院情况。
IEEE J Transl Eng Health Med. 2020 Nov 24;9:3000113. doi: 10.1109/JTEHM.2020.3040236. eCollection 2021.
4
Impact of benzodiazepine consumption reduction on future burden of dementia.减少苯二氮䓬类药物使用对未来痴呆负担的影响。
Sci Rep. 2020 Sep 4;10(1):14666. doi: 10.1038/s41598-020-71482-0.
5
Generating national projections of dementia cases for Ireland using a calibrated macro-simulation model.使用校准的宏观模拟模型生成爱尔兰痴呆症病例的全国预测。
BMJ Open. 2020 Aug 7;10(8):e035463. doi: 10.1136/bmjopen-2019-035463.
6
Fungicide Residues Exposure and Aggregation in a Mouse Model of Alzheimer's Disease.真菌杀菌剂残留暴露与阿尔茨海默病小鼠模型中的聚集。
Environ Health Perspect. 2020 Jan;128(1):17011. doi: 10.1289/EHP5550. Epub 2020 Jan 15.
7
Experiences of advanced dementia care in seven European countries: implications for educating the workforce.七个欧洲国家的晚期痴呆症护理经验:对劳动力培训的启示
Glob Health Action. 2018;11(1):1478686. doi: 10.1080/16549716.2018.1478686.
8
The Korean version of relative and absolute reliability of gait and balance assessment tools for patients with dementia in day care center and nursing home.日间护理中心和养老院中痴呆症患者步态与平衡评估工具的韩国版相对可靠性和绝对可靠性
J Phys Ther Sci. 2017 Nov;29(11):1934-1939. doi: 10.1589/jpts.29.1934. Epub 2017 Nov 24.
9
Dementia Population Risk Tool (DemPoRT): study protocol for a predictive algorithm assessing dementia risk in the community.痴呆症人群风险工具(DemPoRT):一种评估社区痴呆症风险的预测算法的研究方案。
BMJ Open. 2017 Oct 24;7(10):e018018. doi: 10.1136/bmjopen-2017-018018.
10
Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer's disease: the National Finnish population study (FINRISK).载脂蛋白和高密度脂蛋白胆固醇与未来患痴呆症和阿尔茨海默病的风险无关:芬兰全国人口研究(芬兰危险因素干预研究)
Age (Dordr). 2016 Dec;38(5-6):465-473. doi: 10.1007/s11357-016-9950-x. Epub 2016 Sep 23.

本文引用的文献

1
Forecasting the global burden of Alzheimer's disease.预测阿尔茨海默病的全球负担。
Alzheimers Dement. 2007 Jul;3(3):186-91. doi: 10.1016/j.jalz.2007.04.381.
2
Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity?美国认知障碍的患病率和死亡率趋势:是否有证据表明认知发病期被压缩?
Alzheimers Dement. 2008 Mar;4(2):134-44. doi: 10.1016/j.jalz.2008.01.001. Epub 2008 Mar 4.
3
Alzheimer disease and mortality: a 15-year epidemiological study.阿尔茨海默病与死亡率:一项15年的流行病学研究。
Arch Neurol. 2005 May;62(5):779-84. doi: 10.1001/archneur.62.5.779.
4
Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy.60岁后认知障碍和痴呆症的发生情况:一项来自意大利北部的基于人群的研究。
Dement Geriatr Cogn Disord. 2005;19(2-3):97-105. doi: 10.1159/000082660. Epub 2004 Dec 9.
5
Dementia: the leading predictor of death in a defined elderly population: the Cache County Study.痴呆症:特定老年人群中死亡的主要预测因素:卡什县研究
Neurology. 2004 Apr 13;62(7):1156-62. doi: 10.1212/01.wnl.0000118210.12660.c2.
6
A penalized likelihood approach for an illness-death model with interval-censored data: application to age-specific incidence of dementia.一种用于具有区间删失数据的疾病-死亡模型的惩罚似然方法:应用于特定年龄痴呆发病率
Biostatistics. 2002 Sep;3(3):433-43. doi: 10.1093/biostatistics/3.3.433.
7
[Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort].75岁及以上人群中痴呆症和阿尔茨海默病的患病率:PAQUID队列研究的更新结果
Rev Neurol (Paris). 2003 Apr;159(4):405-11.
8
Mortality in patients with dementia after ischemic stroke.缺血性中风后痴呆患者的死亡率。
Neurology. 2002 Aug 27;59(4):537-43. doi: 10.1212/wnl.59.4.537.
9
Mortality with dementia: results from a French prospective community-based cohort.痴呆症导致的死亡率:来自法国一项基于社区的前瞻性队列研究的结果。
Am J Epidemiol. 2001 Oct 1;154(7):642-8. doi: 10.1093/aje/154.7.642.
10
A reevaluation of the duration of survival after the onset of dementia.对痴呆症发病后存活时间的重新评估。
N Engl J Med. 2001 Apr 12;344(15):1111-6. doi: 10.1056/NEJM200104123441501.

法国和欧洲有多少痴呆症病例?2010-2050 年的替代预测和情景。

How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050.

机构信息

INSERM, U888, Pathologies du Système Nerveux, Recherche Epidémiologique et Clinique, Université MontpellierI, Montpellier, France.

出版信息

Eur J Neurol. 2010 Feb;17(2):252-9. doi: 10.1111/j.1468-1331.2009.02783.x. Epub 2009 Oct 1.

DOI:10.1111/j.1468-1331.2009.02783.x
PMID:19796284
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2925047/
Abstract

BACKGROUND AND PURPOSE

The objective of this study is to estimate the number of dementia cases expected to occur in France and Europe over the next few decades until 2050.

METHODS

Our estimates are based on a model using the European incidence data for dementia by age and sex, the relative mortality risks related to dementia stratified by age classes, and the projections of mortality coefficients in the French and European general population.

RESULTS

In France, in 2010, the number of dementia cases should reach 754000, i.e., 1.2% of the general population or 2.8% of the active population. By 2050 this number should be multiplied by 2.4, i.e., 1813000 cases, which will be 2.6% of the total population and 6.2% of the active population. In Europe this number could reach more than 6 millions in 2010 and 14 millions in 2050. The sensitivity analysis performed on French data showed that our projections were robust to the use of alternative data for incidence and relative mortality risk (variation of 5.5% and 6.5%), but very sensitive to hypotheses of evolution of mortality (variation of -22% to 29%).

CONCLUSIONS

The approach used in our study, integrating both the dementia incidence and the mortality in the calculations, allowed us to refine the projections and stress the great sensitivity of the demographic hypotheses forecasts on the evolution of life expectancy. The likely increase is particularly important and confirms that French and European health systems must take this into account when making future plans.

摘要

背景与目的

本研究旨在估算未来几十年至 2050 年法国和欧洲的痴呆症病例数。

方法

我们的估算基于一个模型,该模型使用欧洲按年龄和性别划分的痴呆症发病率数据、按年龄分层的与痴呆症相关的相对死亡率风险以及法国和欧洲一般人群死亡率系数的预测。

结果

在法国,2010 年痴呆症病例数预计将达到 754000 例,占总人口的 1.2%或活跃人口的 2.8%。到 2050 年,这一数字应该乘以 2.4,即 1813000 例,占总人口的 2.6%和活跃人口的 6.2%。在欧洲,2010 年这一数字可能达到 600 多万例,2050 年可能达到 1400 多万例。对法国数据进行的敏感性分析表明,我们的预测对发病率和相对死亡率风险的替代数据的使用具有稳健性(变化幅度为 5.5%和 6.5%),但对死亡率演变的假设非常敏感(变化幅度为-22%至 29%)。

结论

本研究中使用的方法,将痴呆症的发病率和死亡率都纳入计算,使我们能够对预测进行细化,并强调人口假设预测对预期寿命演变的巨大敏感性。这种可能性的增加尤其重要,这证实了法国和欧洲的卫生系统在制定未来计划时必须考虑到这一点。